- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 20.83M sh |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $16.26M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $16.54M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $1.13M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $1.13M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $22.62M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $22.78M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $9.02M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $14.64M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $27.78M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $33.93M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $92.62M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $98.62M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $214.4M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $222.09M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 21.45M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $3K |
| Capex | Q1 2024 · Mar 31, 2023 | $473K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$3.21M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $186.51M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $187M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.03 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.03 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $7.78M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$612K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$893K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $6.93M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $8.29M |
| Revenue | Q1 2024 · Mar 31, 2023 | $15.22M |